These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 21408123)

  • 1. Analysis of antibody and cytokine markers for leprosy nerve damage and reactions in the INFIR cohort in India.
    Jadhav R; Suneetha L; Kamble R; Shinde V; Devi K; Chaduvula MV; Raju R; Suneetha S; Nicholls PG; van Brakel WH; Lockwood DN
    PLoS Negl Trop Dis; 2011 Mar; 5(3):e977. PubMed ID: 21408123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serological responses to prednisolone treatment in leprosy reactions: study of TNF-α, antibodies to phenolic glycolipid-1, lipoarabinomanan, ceramide and S100-B.
    Raju R; Suneetha S; Jadhav RS; Chaduvula M; Atkinson S; Jain S; Visser LH; Das L; Panhalkar R; Shinde V; Reddy PP; Barkataki P; Lockwood DNj; Van Brakel WH; Suneetha LM
    Lipids Health Dis; 2014 Jul; 13():119. PubMed ID: 25070345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine and protein markers of leprosy reactions in skin and nerves: baseline results for the North Indian INFIR cohort.
    Lockwood DN; Suneetha L; Sagili KD; Chaduvula MV; Mohammed I; van Brakel W; Smith WC; Nicholls P; Suneetha S
    PLoS Negl Trop Dis; 2011 Dec; 5(12):e1327. PubMed ID: 22180790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The INFIR Cohort Study: investigating prediction, detection and pathogenesis of neuropathy and reactions in leprosy. Methods and baseline results of a cohort of multibacillary leprosy patients in north India.
    van Brakel WH; Nicholls PG; Das L; Barkataki P; Suneetha SK; Jadhav RS; Maddali P; Lockwood DN; Wilder-Smith E; Desikan KV
    Lepr Rev; 2005 Mar; 76(1):14-34. PubMed ID: 15881033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody response to recombinant 65-kDa, 70-kDa and 18-kDa mycobacterial antigens in leprosy patients and healthy contacts in a leprosy-endemic population.
    Ilangumaran S; Shankernarayan N; Ramu G; Muthukkaruppan V
    Int J Lepr Other Mycobact Dis; 1994 Jun; 62(2):245-55. PubMed ID: 7519226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serological evidence of Toxoplasma gondii infection as potential risk for the development of lepromatous leprosy in an endemic area for both neglected tropical diseases in Brazil.
    Oliveira LRP; Martins LM; Souza RDC; Scheidegger de Castro Y; Nascimento LS; da Silva JA; Nahn Junior EP; da Silva WD; Peixoto-Rangel AL
    Infect Dis Poverty; 2020 Feb; 9(1):19. PubMed ID: 32051036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specificity of IgG subclass antibodies in different clinical manifestations of leprosy.
    Dhandayuthapani S; Izumi S; Anandan D; Bhatia VN
    Clin Exp Immunol; 1992 May; 88(2):253-7. PubMed ID: 1572088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing the clinical and histological diagnosis of leprosy and leprosy reactions in the INFIR cohort of Indian patients with multibacillary leprosy.
    Lockwood DN; Nicholls P; Smith WC; Das L; Barkataki P; van Brakel W; Suneetha S
    PLoS Negl Trop Dis; 2012; 6(6):e1702. PubMed ID: 22745841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential monitoring of leprosy patients with serum antibody levels to phenolic glycolipid-I, a synthetic analog of phenolic glycolipid-I, and mycobacterial lipoarabinomannan.
    Meeker HC; Schuller-Levis G; Fusco F; Giardina-Becket MA; Sersen E; Levis WR
    Int J Lepr Other Mycobact Dis; 1990 Sep; 58(3):503-11. PubMed ID: 2205685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Class-specific immunoglobulins and antibodies to mycobacterial sonicates and autoantigens in leprosy patients and contacts.
    Mathew JM; Muthukkaruppan V
    Microb Pathog; 1993 Nov; 15(5):367-76. PubMed ID: 8015417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can anti-PGL-1 and anti-NDO-LID-1 antibody titers be used to predict the risk of reactions in leprosy patients?
    Devides AC; Rosa PS; de Faria Fernandes Belone A; Coelho NMB; Ura S; Silva EA
    Diagn Microbiol Infect Dis; 2018 Jul; 91(3):260-265. PubMed ID: 29669693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leprosy reactions: The predictive value of Mycobacterium leprae-specific serology evaluated in a Brazilian cohort of leprosy patients (U-MDT/CT-BR).
    Hungria EM; Bührer-Sékula S; de Oliveira RM; Aderaldo LC; Pontes AA; Cruz R; Gonçalves HS; Penna ML; Penna GO; Stefani MM
    PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005396. PubMed ID: 28222139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistological analysis of in situ expression of mycobacterial antigens in skin lesions of leprosy patients across the histopathological spectrum. Association of Mycobacterial lipoarabinomannan (LAM) and Mycobacterium leprae phenolic glycolipid-I (PGL-I) with leprosy reactions.
    Verhagen C; Faber W; Klatser P; Buffing A; Naafs B; Das P
    Am J Pathol; 1999 Jun; 154(6):1793-804. PubMed ID: 10362804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of anti-PGL-I as a prognostic marker of leprosy reaction.
    Stefani MM; Martelli CM; Morais-Neto OL; Martelli P; Costa MB; de Andrade AL
    Int J Lepr Other Mycobact Dis; 1998 Sep; 66(3):356-64. PubMed ID: 9934362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of S-100 protein and anticeramide antibodies in leprosy patients by ELISA.
    Narayan R; Maheshwari PK; Desikan KV; Harinath BC
    Lepr Rev; 1997 Jun; 68(2):117-24. PubMed ID: 9217350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of immunoglobulin isotypes against LID-1 and NDO-LID for, particularly IgG1, confirming the diagnosis of multibacillary leprosy.
    Marçal PHF; Fraga LAO; Mattos AMM; Menegati L; Coelho ADCO; Pinheiro RO; Sarno EN; Duthie MS; Teixeira HC
    Mem Inst Oswaldo Cruz; 2018; 113(5):e170467. PubMed ID: 29513821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgG subclass distribution of antibody responses to protein and polysaccharide mycobacterial antigens in leprosy and tuberculosis patients.
    Sousa AO; Henry S; Marója FM; Lee FK; Brum L; Singh M; Lagrange PH; Aucouturier P
    Clin Exp Immunol; 1998 Jan; 111(1):48-55. PubMed ID: 9472660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoglobulin G1 (IgG1) and IgG3 antibodies are markers of progressive disease in leprosy.
    Hussain R; Kifayet A; Chiang TJ
    Infect Immun; 1995 Feb; 63(2):410-5. PubMed ID: 7822004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of Anti-Phenolic Glycolipid-I antibody in sera from tuberculosis patients in Bandung, West Java, Indonesia.
    Gunawan H; Roslina N; Agusni JH; Kulsum ID; Makarti K; Hindritiani R; Suwarsa O
    Int J Mycobacteriol; 2019; 8(2):166-169. PubMed ID: 31210160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The INFIR Cohort Study: assessment of sensory and motor neuropathy in leprosy at baseline.
    Van Brakel WH; Nicholls PG; Das L; Barkataki P; Maddali P; Lockwood DN; Wilder-Smith E
    Lepr Rev; 2005 Dec; 76(4):277-95. PubMed ID: 16411508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.